drugset / Trial / NCT01667029
Study of Sulfasalazine in Treating Painful Neuropathy
RandomizedCrossoverQuadruple-blindTreatment
Summary
The investigators hypothesize that sulfasalazine, an FDA-approved medication for rheumatoid arthritis and ulcerative colitis, may be beneficial in neuropathic pain conditions. In this study, the investigators will evaluate whether sulfasalazine improves pain due to painful peripheral neuropathy.
Timeline
- Start
- 2013-05
- Primary completion
- 2017-08-10
- Completion
- 2017-08-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sulfasalazine | Small molecule | 1 g | Oral |